{"id":823465,"date":"2025-03-10T07:36:23","date_gmt":"2025-03-10T11:36:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zimmer-biomet-highlights-diverse-portfolio-of-orthopedic-musculoskeletal-innovations-at-aaos-2025-annual-meeting\/"},"modified":"2025-03-10T07:36:23","modified_gmt":"2025-03-10T11:36:23","slug":"zimmer-biomet-highlights-diverse-portfolio-of-orthopedic-musculoskeletal-innovations-at-aaos-2025-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zimmer-biomet-highlights-diverse-portfolio-of-orthopedic-musculoskeletal-innovations-at-aaos-2025-annual-meeting\/","title":{"rendered":"Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities Reconstructive Technologies, Including Recently Cleared Persona\u00ae<\/sup> Revision SoluTion\u2122 Femur, and Debut of ZBX\u2122 Ambulatory Surgery Center Solutions <\/i>
\n <\/b>\n <\/p>\n

\n WARSAW,\u00a0Ind.<\/span>, March 10, 2025<\/span><\/span> \/PRNewswire\/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader,\u00a0today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting being held March 10-14<\/span> in San Diego<\/span>. During the meeting, the Company’s booth will prominently feature its comprehensive hip portfolio, anchored by the new Z1\u2122 Triple-Taper Femoral Hip System, along with the latest technologies for knee and upper extremity reconstruction and key components from its robotic solutions. In addition, Zimmer Biomet is debuting ZBX\u2122<\/sup>, its new Ambulatory Surgery Center (ASC) offering to surgeons and institutions looking to expand their orthopedic footprint.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Zimmer
\n <\/a>\n <\/p>\n<\/p><\/div>\n

“I am thrilled to showcase the collective strength and broad range of our musculoskeletal portfolio, including the introduction of several recently cleared technologies, at this year’s annual AAOS meeting,” said Ivan Tornos, President and Chief Executive Officer at Zimmer Biomet. “We are in the midst of one of the largest innovation cycles in our company’s history. Our broad hip reconstruction portfolio combined with our comprehensive knee portfolio with constructs designed to safeguard against cement and metal sensitivities, our bone-preserving stemless shoulder and now an enhanced suite of ASC solutions, squarely position us at the forefront of delivering customer-centric innovations to improve efficiency and overall patient outcomes.”<\/p>\n

The highlights at the Zimmer Biomet booth (#3129) include:<\/p>\n

\n Hip Reconstruction Technologies<\/b>\n <\/p>\n